InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Whitescarver David, VP du Développement Corporatif et de la PI. Director active across 1 company, notably Cardiovascular Systems Inc. In total, 10 disclosures have been recorded. History available since 9 August 2021. The latest transaction was disclosed on 8 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations10 total
5,477 shares0Common StockSEC:0001437749-22-002887:0
5,477 shares0Common StockSEC:0001437749-22-002887
429 shares@ US$27.208.7% of flowCommon StockSEC:0000914190-21-000409:0
429 shares@ US$27.208.7% of flowCommon StockSEC:0000914190-21-000409
1,015 shares0Common StockSEC:0000914190-21-000304:0
1,015 shares0Common StockSEC:0000914190-21-000304
1,568 shares@ US$36.0741.3% of flowCommon StockSEC:0000914190-21-000264:0
1,568 shares@ US$36.0741.3% of flowCommon StockSEC:0000914190-21-000264
3,994 shares0Common StockSEC:0000914190-21-000242:0
3,994 shares0Common StockSEC:0000914190-21-000242
10 of 10 declarations
About Whitescarver David
David Whitescarver is the VP of Corp. Dev. and IP at Cardiovascular Systems Inc. He is responsible for the company's business development strategy and intellectual property management. With a strong background in the medical sector, he plays a key role in identifying growth opportunities and protecting innovations. His expertise contributes to the company's competitiveness and sustainability.
